STAT3 signaling in myeloid cells promotes pathogenic myelin-specific T cell differentiation and autoimmune demyelination.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
10 03 2020
Historique:
pubmed: 26 2 2020
medline: 14 7 2020
entrez: 26 2 2020
Statut: ppublish

Résumé

Multiple sclerosis (MS) is an autoimmune inflammatory demyelinating disease of the central nervous system. Dysregulation of STAT3, a transcription factor pivotal to various cellular processes including Th17 cell differentiation, has been implicated in MS. Here, we report that STAT3 is activated in infiltrating monocytic cells near active MS lesions and that activation of STAT3 in myeloid cells is essential for leukocyte infiltration, neuroinflammation, and demyelination in experimental autoimmune encephalomyelitis (EAE). Genetic disruption of

Identifiants

pubmed: 32094172
pii: 1913997117
doi: 10.1073/pnas.1913997117
pmc: PMC7071888
doi:

Substances chimiques

CD11b Antigen 0
STAT3 Transcription Factor 0
Stat3 protein, mouse 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

5430-5441

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK098662
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK121805
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS060017
Pays : United States

Informations de copyright

Copyright © 2020 the Author(s). Published by PNAS.

Déclaration de conflit d'intérêts

The authors declare no competing interest.

Références

J Clin Med. 2018 Dec 03;7(12):
pubmed: 30513926
J Immunol. 1998 Oct 1;161(7):3767-75
pubmed: 9759903
J Neuroimmunol. 2007 Dec;192(1-2):174-83
pubmed: 17904647
JCI Insight. 2019 Apr 2;5:
pubmed: 30939124
Blood. 2010 Oct 28;116(17):3208-18
pubmed: 20634378
Immunity. 2000 Sep;13(3):345-53
pubmed: 11021532
J Immunol. 2008 May 1;180(9):6070-6
pubmed: 18424728
J Neurol. 2017 Feb;264(2):254-259
pubmed: 27878439
Cell. 2018 Nov 29;175(6):1679-1687.e7
pubmed: 30343897
J Neuropathol Exp Neurol. 2013 Dec;72(12):1135-44
pubmed: 24226263
Nat Rev Immunol. 2007 Feb;7(2):155-61
pubmed: 17220916
Ann Neurol. 2004 Mar;55(3):410-7
pubmed: 14991819
Cell. 2013 Dec 19;155(7):1596-609
pubmed: 24360280
J Clin Invest. 2003 May;111(9):1297-308
pubmed: 12727921
Lancet. 2008 Oct 25;372(9648):1502-17
pubmed: 18970977
Brain. 2012 May;135(Pt 5):1586-605
pubmed: 22447120
Neurobiol Dis. 2016 Jul;91:336-46
pubmed: 27060559
J Immunol. 1998 Dec 15;161(12):6480-6
pubmed: 9862671
J Immunol. 1998 Nov 1;161(9):4652-60
pubmed: 9794394
Immunity. 2008 Apr;28(4):477-87
pubmed: 18400190
Immunity. 1999 Jan;10(1):39-49
pubmed: 10023769
J Exp Med. 2006 Apr 17;203(4):1007-19
pubmed: 16585265
J Immunol. 2013 Nov 1;191(9):4531-9
pubmed: 24062488
Nat Neurosci. 2018 Apr;21(4):541-551
pubmed: 29507414
Nature. 2011 Aug 10;476(7359):214-9
pubmed: 21833088
Clin Transl Immunology. 2018 May 31;7(6):e1018
pubmed: 29881546
Annu Rev Immunol. 2005;23:683-747
pubmed: 15771584
Blood. 2009 Apr 2;113(14):3190-7
pubmed: 19196868
J Immunol. 1998 Oct 1;161(7):3299-306
pubmed: 9759845
J Neurosci Res. 2006 Oct;84(5):1027-36
pubmed: 16865709
Science. 2019 Jan 25;363(6425):
pubmed: 30679343
Eur J Immunol. 1998 Jul;28(7):2178-87
pubmed: 9692887
Nat Neurosci. 2011 Jul 31;14(9):1142-9
pubmed: 21804537
J Neuroimmunol. 1999 Nov 15;101(2):188-96
pubmed: 10580801
Nat Med. 2005 Mar;11(3):328-34
pubmed: 15735653
J Exp Med. 2000 Sep 18;192(6):899-905
pubmed: 10993920
Hum Mol Genet. 2009 Jun 1;18(11):2078-90
pubmed: 19286671
Am J Hum Genet. 2010 Feb 12;86(2):285-91
pubmed: 20159113
Proc Natl Acad Sci U S A. 2012 Mar 27;109(13):5004-9
pubmed: 22411837
Ann Neurol. 1995 Nov;38(5):788-96
pubmed: 7486871
Cell. 1993 Oct 22;75(2):263-74
pubmed: 8402911
Ann Neurol. 2009 Dec;66(6):739-53
pubmed: 20035511
Nat Rev Neurol. 2016 Sep;12(9):539-51
pubmed: 27514287
J Immunol. 2004 Oct 15;173(8):5209-18
pubmed: 15470066
J Exp Med. 2000 Oct 2;192(7):1075-80
pubmed: 11015448
J Immunol. 2014 Jan 1;192(1):59-72
pubmed: 24323580
Nat Rev Immunol. 2013 May;13(5):321-35
pubmed: 23618829
J Exp Med. 2003 May 5;197(9):1073-81
pubmed: 12732654
Ann Neurol. 2009 Apr;65(4):457-69
pubmed: 18496841
Mult Scler. 2013 Dec;19(14):1841-8
pubmed: 24085340
J Autoimmun. 2015 Nov;64:13-25
pubmed: 26142251
Immunology. 2019 Jan;156(1):23-32
pubmed: 30259972
J Neuroimmunol. 1994 May;51(2):135-46
pubmed: 8182113
J Neurochem. 2016 Feb;136(4):826-836
pubmed: 26560636
Brain Pathol. 2012 Jan;22(1):41-57
pubmed: 21615590
Neurogenetics. 2012 Feb;13(1):83-6
pubmed: 22095036
Nature. 2009 Nov 5;462(7269):94-8
pubmed: 19829296
J Neuroinflammation. 2018 Mar 7;15(1):72
pubmed: 29514694
J Biol Chem. 2008 Apr 4;283(14):9465-74
pubmed: 18245084
J Exp Med. 2015 Jan 12;212(1):23-35
pubmed: 25559893

Auteurs

Hsueh Chung Lu (HC)

Department of Veterinary Integrative Biosciences, Texas A&M University, College Station, TX 77843.

Sunja Kim (S)

Department of Veterinary Integrative Biosciences, Texas A&M University, College Station, TX 77843.

Andrew J Steelman (AJ)

Department of Veterinary Integrative Biosciences, Texas A&M University, College Station, TX 77843.

Kevin Tracy (K)

Texas A&M Institute for Genome Sciences and Society, Texas A&M University, College Station, TX 77843.

Beiyan Zhou (B)

Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX 77843.

Danielle Michaud (D)

Department of Veterinary Integrative Biosciences, Texas A&M University, College Station, TX 77843.

Andrew E Hillhouse (AE)

Texas A&M Institute for Genome Sciences and Society, Texas A&M University, College Station, TX 77843.

Kranti Konganti (K)

Texas A&M Institute for Genome Sciences and Society, Texas A&M University, College Station, TX 77843.

Jianrong Li (J)

Department of Veterinary Integrative Biosciences, Texas A&M University, College Station, TX 77843; jrli@cvm.tamu.edu.
Institute for Neuroscience, Texas A&M University, College Station, TX 77843.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH